Edition:
India

Amyris Inc (AMRS.OQ)

AMRS.OQ on NASDAQ Stock Exchange Global Select Market

3.63USD
12 Dec 2017
Change (% chg)

$0.03 (+0.83%)
Prev Close
$3.60
Open
$3.57
Day's High
$3.75
Day's Low
$3.55
Volume
21,818
Avg. Vol
72,418
52-wk High
$12.38
52-wk Low
$1.86

Latest Key Developments (Source: Significant Developments)

Amyris posts Q3 GAAP loss of $1.14 per share
Wednesday, 15 Nov 2017 

Nov 14 (Reuters) - Amyris Inc :Amyris reports another strong quarter of product sales growth and expects strong finish for 2017.Q3 GAAP loss per share $1.14.Q3 revenue $24.2 million versus $26.5 million.Qtrly non-GAAP basic loss per share $‍0.81​.  Full Article

Amyris says collaboration with pharmaceutical company for biosynthetic drug discovery
Friday, 28 Oct 2016 

Amyris Inc :Amyris inc -collaboration with pharmaceutical company for biosynthetic drug discovery.  Full Article

Amyris agrees to collaborate with leading global food ingredients and nutraceuticals partner
Thursday, 13 Oct 2016 

Amyris Inc : Amyris agrees to collaboration terms with leading global food ingredients and nutraceuticals partner . Amyris Inc - expects to receive cash representing a short-term collaboration investment of $10 million .Amyris inc - expects to receive an equity investment of up to $20 million at $1.40 per share, $100 million in annual revenue starting in 2017.  Full Article

Amyris expanded its strategic partnership with a "global nutraceuticals market leader"
Friday, 30 Sep 2016 

Amyris Inc : Expanded its strategic partnership with a "global nutraceuticals market leader" . New agreement includes addition of a new nutraceutical target, a credit line of up to $25 million with a 5-year maturity . Says anticipated revenues from expanded partnership are expected to average over $70 million annually beyond 2017 .New agreement includes an option for a $5-million strategic investment.  Full Article

Amyris Q2 adjusted loss per share $0.15
Friday, 5 Aug 2016 

Amyris Inc : Q2 loss per share $0.06 . Q2 2016 GAAP revenues of $9.6 million (non-GAAP revenues of $12.4 million) . Amyris reports second quarter 2016 results .Q2 adjusted loss per share $0.15 excluding items.  Full Article

Amyris enters partnership with Biogen
Wednesday, 3 Aug 2016 

Amyris Inc : Collaboration will explore use of Amyris's microbe engineering technology .Amyris enters partnership with Biogen to develop alternative cell lines supporting production of therapeutics.  Full Article

American Refining Group invests in Novvi to accelerate Amyris commercialization of renewable base oil and lubricant platform
Tuesday, 19 Jul 2016 

Amyris Inc : American Refining Group invests in Novvi to accelerate Amyris commercialization of renewable base oil and lubricant platform .Committed to 33.3% equity investment into JV, Amyris & Cosan to continue to hold share ownership stakes in Novvi, with ARG.  Full Article

Amyris entered into note purchase agreement with Foris Ventures LLC
Thursday, 30 Jun 2016 

Amyris Inc : On June 24, 2016 entered into note purchase agreement with Foris Ventures LLC for sale of $5 million in aggregate principal amount of secured promissory notes .Interest will accrue on notes from & including June 24, 2016 at a rate of 13.50% per annum and is payable in full on May 15, 2017- sec filing.  Full Article

Amyris Inc enters into strategic partnership agreement with Ginkgo Bioworks
Wednesday, 29 Jun 2016 

: Amyris inc says on june 28, 2016 co entered into a strategic partnership agreement with ginkgo bioworks, inc . Amyris inc says co will transfer certain intellectual property to ginkgo by june 30, 2016 in exchange for a fee of $20 million to be paid by ginkgo . Amyris inc says co would issue to ginkgo an option to purchase 5 million shares of common stock of company at an exercise price of $0.50 Source - http://1.usa.gov/294nhM3 (Bengaluru Newsroom; +1 646 223 8780).  Full Article

Ginkgo Bioworks says partners with Amyris Inc
Wednesday, 29 Jun 2016 

Ginkgo Bioworks - : Co, Amyris announced partnership, which will enable companies to jointly develop products .Partnership is expected to generate over $300 million in incremental value for both companies over next 5 years.  Full Article

BRIEF-DSM acquires Brazilian production facility from Amyris

* DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris